Signup Crypto ETF Stocks News

Coinbase Global ( COIN ) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates

While the top- and bottom-line numbers for Coinbase Global (COIN) give a sense of how the business performed in the quarter ended December 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Source: www.zacks.com
February 13, 2025 | 23:30:09
Category: News

Kinsale Capital Group ( KNSL ) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates

Although the revenue and EPS for Kinsale Capital Group (KNSL) give a sense of how its business performed in the quarter ended December 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Source: www.zacks.com
February 13, 2025 | 23:30:10
Category: News

Here's What Key Metrics Tell Us About Twilio ( TWLO ) Q4 Earnings

While the top- and bottom-line numbers for Twilio (TWLO) give a sense of how the business performed in the quarter ended December 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Source: www.zacks.com
February 13, 2025 | 23:30:10
Category: News

Fortis Inc. Announces Second Quarter Dividends - 2025

This news release constitutes a "Designated News Release" incorporated by reference in the prospectus supplement dated December 9, 2024 to Fortis' short form base shelf prospectus dated December 9, 2024.

Source: www.globenewswire.com
February 13, 2025 | 23:33:00
Category: News

Fortis Inc. Announces Second Quarter Dividends - 2025 - Fortis ( NYSE:FTS )

This news release constitutes a "Designated News Release" incorporated by reference in the prospectus supplement dated December 9, 2024 to Fortis' short form base shelf prospectus dated December 9, 2024.

Source: www.benzinga.com
February 13, 2025 | 23:33:31
Category: News

Ryoncil® FDA Approval and Market Launch Highlighted at Tandem Transplantation Meetings

NEW YORK, Feb. 13, 2025 ( GLOBE NEWSWIRE ) -- Mesoblast Limited ( Nasdaq:MESO. ASX:MSB ) , a global leader in allogeneic cellular medicines for inflammatory diseases, today announced that its recently approved product Ryoncil® ( remestemcel-L ) is being highlighted at the 2025 Transplantation & ...

Source: www.globenewswire.com
February 13, 2025 | 23:37:00
Category: News

Ryoncil® FDA Approval and Market Launch Highlighted at Tandem Transplantation Meetings - Mesoblast ( NASDAQ:MESO )

NEW YORK, Feb. 13, 2025 ( GLOBE NEWSWIRE ) -- Mesoblast Limited MESOMSB ) , a global leader in allogeneic cellular medicines for inflammatory diseases, today announced that its recently approved product Ryoncil® ( remestemcel-L ) is being highlighted at the 2025 Transplantation & Cellular ...

Source: www.benzinga.com
February 13, 2025 | 23:37:36
Category: News

How to Buy Gold Right Now

Tracey Ryniec and Neena Mishra, Zacks Director of ETF Research, discuss the hot gold rally, gold stocks and ETFs.

Source: www.zacks.com
February 13, 2025 | 23:41:00
Category: News

Applied Materials Hits Its Q1 Guidance

Applied Materials reported record revenue in its fiscal 2025 first quarter, but a significant overseas tax charge impacted its bottom line.

Source: www.fool.com
February 13, 2025 | 23:47:38
Category: News

FEMSA Schedules Conference Call to Discuss Fourth Quarter and Full Year 2024 Financial Results

MONTERREY, Mexico, Feb. 13, 2025 ( GLOBE NEWSWIRE ) -- Fomento Económico Mexicano, S.A.B. de C.V. ( "FEMSA" or the "Company" ) ( NYSE: FMX. BMV: FEMSAUBD, FEMSAUB ) is pleased to invite you to participate in its Fourth Quarter and Full Year 2024 Conference Call that will be held on: ...

Source: www.globenewswire.com
February 13, 2025 | 23:51:00
Category: News

© Natavest 2025 - 2026